2012
DOI: 10.2174/092986712798992011
|View full text |Cite
|
Sign up to set email alerts
|

Approaches Targeting KV10.1 Open a Novel Window for Cancer Diagnosis and Therapy

Abstract: K(V)10.1 has recently become generally accepted as a promising cancer target, as it is ectopically expressed in the majority of solid tumors. Due to its cell-surface accessibility, K(V)10.1 has a strong potential for tumor treatment and diagnosis. Given that its mode of action is likely independent of conventional cancer pathways such as tyrosine kinases, K(V)10.1 opens a novel window for treating cancer. In this review we will give an overview of the current status of data linking K(V)10.1 to cancer, and prop… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
31
0
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(32 citation statements)
references
References 87 publications
(111 reference statements)
0
31
0
1
Order By: Relevance
“…Thus increased TREK-1 channel expression is associated with abnormal cell proliferation in prostate cancer cell lines and TREK-1 may be a novel molecular target in prostate cancer (Voloshyna et al, 2008). The K v 10.1 (KCNH1) channel, which is widely studied in cancer, is important for cell cycle progression and is regulated through the cell cycle (Pardo et al, 2012). Thus, developing specific blockers for these channels in the treatment of cancer is a promising field (Felipe et al, 2006; Li and Xiong, 2011; Pardo et al, 2012).…”
Section: Roles Of Cell Volume Regulation In Cell Proliferation and Prmentioning
confidence: 99%
“…Thus increased TREK-1 channel expression is associated with abnormal cell proliferation in prostate cancer cell lines and TREK-1 may be a novel molecular target in prostate cancer (Voloshyna et al, 2008). The K v 10.1 (KCNH1) channel, which is widely studied in cancer, is important for cell cycle progression and is regulated through the cell cycle (Pardo et al, 2012). Thus, developing specific blockers for these channels in the treatment of cancer is a promising field (Felipe et al, 2006; Li and Xiong, 2011; Pardo et al, 2012).…”
Section: Roles Of Cell Volume Regulation In Cell Proliferation and Prmentioning
confidence: 99%
“…However, the physiological or potentially pathophysiological role of K v 11.1 and K v 10.2 channels remains unclear. The related K v 10.1 ( KCNH1 ) channel has been shown to be upregulated in several cancers including pancreatic cancer, based on studies of human pancreatic adenocarcinoma cell lines 100 , 101 …”
Section: Kcnh2 (Kv111 Herg) and Kcnh5 (Kv102 Eag2)mentioning
confidence: 99%
“…На примере раковых клеток простаты показано, что увеличенная ýкспрессия канала K 2P 2.1 (TREK-1), являющегося представителем семейства двупоро-вых каналов, связана с нарушениями пролифера-ции клеток [97]. Есть данные, что активация по-тенциал-зависимых К + -каналов (KV10.1) является необходимой для продвижения клеточного цикла [98]. Помимо потенциал-зависимых К + -каналов [99] [104], клетках плоскоклеточного рака головы и шеи [105], клетках рака молочной железы [106].…”
Section: значение в норме и при патологииunclassified